HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on MediWound (NASDAQ:MDWD) and maintained a price target of $28.
August 15, 2024 | 11:58 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on MediWound and maintained a price target of $28.
The reiteration of a Buy rating and maintenance of a $28 price target by HC Wainwright & Co. is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100